Published in J HIV Ther on March 01, 2007
CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian guidelines for management and treatment of HIV/hepatitis C coinfection in adults. Can J Infect Dis Med Microbiol (2013) 0.84
Management complexities of HIV/hepatitis C virus coinfection in the twenty-first century. Clin Liver Dis (2008) 0.83
Pros and cons of liver transplantation in human immunodeficiency virus infected recipients. World J Gastroenterol (2014) 0.76
Solid organ transplantation and HIV: A changing paradigm. Can J Infect Dis Med Microbiol (2008) 0.75
Liver transplant outcomes in HIV+ haemophilic men. Haemophilia (2012) 0.75
CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment. Can J Infect Dis Med Microbiol (2016) 0.75
Liver transplantation for patients with human immunodeficiency virus and hepatitis C virus coinfection with special reference to hemophiliac recipients in Japan. Surg Today (2011) 0.75
MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation. Gut (2007) 2.09
[Costs and cost effectiveness analysis of preferred GESIDA regimens for initial antiretroviral therapy]. Enferm Infecc Microbiol Clin (2011) 2.03
[Costs and cost-efficacy analysis of the preferred treatments by GESIDA/National Plan for AIDS for the initial antiretroviral therapy in adult human immunodeficiency virus (HIV) infected patients in 2012]. Enferm Infecc Microbiol Clin (2012) 2.02
Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation (2010) 2.01
Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis (2009) 1.83
Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med (2009) 1.76
The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study. Liver Transpl (2009) 1.65
Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients. Clin Infect Dis (2008) 1.58
Preconditioning protects liver and lung damage in rat liver transplantation: role of xanthine/xanthine oxidase. Hepatology (2002) 1.54
Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients: a FIPSE/GESIDA prospective cohort study. Liver Transpl (2012) 1.53
Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation. Clin Infect Dis (2008) 1.51
Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplant. Liver Transpl (2008) 1.48
[Drug related problems as a cause of hospital admission]. Med Clin (Barc) (2002) 1.48
[Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)]. Enferm Infecc Microbiol Clin (2004) 1.42
The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients. Antivir Ther (2007) 1.33
The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J (2007) 1.26
Patients at risk of complications of Staphylococcus aureus bloodstream infection. Clin Infect Dis (2009) 1.20
Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med (2008) 1.16
A new multidisciplinary home care telemedicine system to monitor stable chronic human immunodeficiency virus-infected patients: a randomized study. PLoS One (2011) 1.15
[Analysis of costs and cost-effectiveness of preferred GESIDA/National AIDS Plan regimens for initial antiretroviral therapy in human immunodeficiency virus infected adult patients in 2013]. Enferm Infecc Microbiol Clin (2013) 1.11
High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis. Antimicrob Agents Chemother (2012) 1.08
Neglecting Enterococci May Lead to a Misinterpretation of the Consequences of Last Changes in Endocarditis Prophylaxis American Heart Association Guidelines. J Am Coll Cardiol (2015) 1.07
[Human immunodeficiency virus-infected patients with community-acquired pneumonia: implication of respiratory viruses]. Enferm Infecc Microbiol Clin (2008) 1.06
Risk factors, clinical features, and outcomes of toxoplasmosis in solid-organ transplant recipients: a matched case-control study. Clin Infect Dis (2011) 1.04
Abacavir does not influence the rate of virological response in HIV-HCV-coinfected patients treated with pegylated interferon and weight-adjusted ribavirin. Antivir Ther (2008) 0.99
Influence of diabetes mellitus on the clinical manifestations and prognosis of infective endocarditis: a report from the International Collaboration on Endocarditis-Merged Database. Scand J Infect Dis (2006) 0.98
Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patients. J Acquir Immune Defic Syndr (2007) 0.93
Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy. Am J Gastroenterol (2009) 0.93
Management of end stage liver disease (ESLD): what is the current role of orthotopic liver transplantation (OLT)? J Hepatol (2005) 0.92
Dual therapy with etravirine plus raltegravir for virologically suppressed HIV-infected patients: a pilot study. J Antimicrob Chemother (2013) 0.91
Clinical utility of daptomycin in infective endocarditis caused by Gram-positive cocci. Int J Antimicrob Agents (2011) 0.91
Highly active antiretroviral therapy (HAART) modifies the incidence and outcome of visceral leishmaniasis in HIV-infected patients. J Acquir Immune Defic Syndr (2002) 0.90
[GESIDA/GESITRA-SEIMC, PNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patients in Spain (March, 2005)]. Enferm Infecc Microbiol Clin (2005) 0.90
Infective Endocarditis in Intravenous Drug Abusers. Curr Infect Dis Rep (2003) 0.89
Risk factors, clinical features, and outcomes of listeriosis in solid-organ transplant recipients: a matched case-control study. Clin Infect Dis (2009) 0.89
GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients. Enferm Infecc Microbiol Clin (2011) 0.88
Toxoplasma gondii primary infection in renal transplant recipients. Two case reports and literature review. Transpl Int (2010) 0.88
An assessment of thromboelastometry to monitor blood coagulation and guide transfusion support in liver transplantation. Transfusion (2012) 0.87
Renal transplantation in HIV-infected patients: 2010 update. Kidney Int (2011) 0.86
Postoperative pain relief after hepatic resection in cirrhotic patients: the efficacy of a single small dose of ketamine plus morphine epidurally. Anesth Analg (2003) 0.86
Gynecomastia among HIV-infected patients is associated with hypogonadism: a case-control study. Clin Infect Dis (2004) 0.86
Candida dubliniensis endophthalmitis in a HIV-infected intravenous drug abuser. Mycoses (2011) 0.86
Pegylated IFN-alpha2b plus ribavirin for treatment-naive patients coinfected with HCV and HIV. Expert Rev Anti Infect Ther (2008) 0.86
Clinicoimmunological progression and response to treatment of long-term nonprogressor HIV-hepatitis C virus-coinfected patients. AIDS Res Hum Retroviruses (2007) 0.85
Effect of thymoglobulin induction on HIV-infected renal transplant recipients: differences between HIV-positive and HIV-negative patients. AIDS Res Hum Retroviruses (2007) 0.85
Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin. Antimicrob Agents Chemother (2013) 0.85
Cytokine-release patterns in elderly patients with systemic inflammatory response syndrome. Gerontology (2007) 0.84
Renal dysfunction in the setting of HIV/AIDS. Curr HIV/AIDS Rep (2012) 0.84
Early virological failure in treatment-naive HIV-infected adults receiving didanosine and tenofovir plus efavirenz or nevirapine. AIDS (2005) 0.83
Influence of age in renal transplant infections: cases and controls study. Transplantation (2005) 0.82
Outcome of Clostridium difficile-associated disease in solid organ transplant recipients: a prospective and multicentre cohort study. Transpl Int (2012) 0.82
Pharmacokinetic study of saquinavir 500 mg plus ritonavir (1000/100 mg twice a day) in HIV-positive pregnant women. Ther Drug Monit (2011) 0.81
Management of dyslipidaemia in HIV-infected patients receiving antiretroviral therapy. Antivir Ther (2004) 0.81
Risk factors for pericardial effusion in native valve infective endocarditis and its influence on outcome. Am J Cardiol (2013) 0.81
[Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update]. Enferm Infecc Microbiol Clin (2011) 0.80
Impact of hepatitis C virus infection on the risk of infectious complications after kidney transplantation: data from the RESITRA/REIPI cohort. Transplantation (2011) 0.80
A novel exon 5 mutation (N139H) in the SOD1 gene in a Spanish family associated with incomplete penetrance. J Neurol Sci (2004) 0.79
Pharmacogenetics of efficacy and safety of HCV treatment in HCV-HIV coinfected patients: significant associations with IL28B and SOCS3 gene variants. PLoS One (2012) 0.79
Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015). Enferm Infecc Microbiol Clin (2015) 0.79
[Specialized home care for infectious disease. Experience from 1995 to 2002]. Enferm Infecc Microbiol Clin (2007) 0.79
The use of beta-adrenergic drugs improves hepatic oxygen metabolism in cirrhotic patients undergoing liver resection. J Hepatol (2009) 0.78
Immune reconstitution syndrome after voriconazole treatment for cryptococcal meningitis in a liver transplant recipient. Liver Transpl (2008) 0.78
A novel exon 3 mutation (D76V) in the SOD1 gene associated with slowly progressive ALS. Amyotroph Lateral Scler Other Motor Neuron Disord (2002) 0.78
[Inflammatory response in elderly patients with bacteremia]. Enferm Infecc Microbiol Clin (2008) 0.78
A review of critical periods for opportunistic infection in the new transplantation era. Transplantation (2006) 0.78
STARTVerso4: faldaprevir and pegylated interferon α-2a/ribavirin in individuals co-infected with hepatitis C virus genotype-1 and HIV. AIDS (2015) 0.78
[Comparison of three methods to calculate adherence in patients receiving antiretroviral treatment]. Enferm Infecc Microbiol Clin (2002) 0.78
[Adverse side effects of antiretroviral therapy: relationship between patients' perception and adherence]. Med Clin (Barc) (2007) 0.78
Influence of repeated cycles of structured therapy interruption on the rate of recovery of CD4+ T cells after highly active antiretroviral therapy resumption. J Antimicrob Chemother (2008) 0.78
Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity. Scand J Infect Dis (2008) 0.77
[Recommendations of the Spanish AIDS Study Group (GESIDA) and the National Aids Plan (PNS) for antiretroviral treatment in adult patients with human immunodeficiency virus infection in 2002]. Enferm Infecc Microbiol Clin (2002) 0.76
Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014). Enferm Infecc Microbiol Clin (2014) 0.76
Incidence and outcome of early Candida peritonitis after liver and pancreas transplantation. Mycoses (2012) 0.76
A novel thymidine phosphorylase mutation in a Spanish MNGIE patient. J Neurol Sci (2004) 0.76
Universal prophylaxis with fluconazole for the prevention of early invasive fungal infection in low-risk liver transplant recipients. Transplantation (2011) 0.76
High rate of virological failure in maintenance antiretroviral therapy with didanosine and tenofovir. AIDS (2005) 0.76
Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis. Acta Derm Venereol (2009) 0.76
[Liver transplantation in patients with HIV infection: a reality in 2004]. Enferm Infecc Microbiol Clin (2004) 0.75
Faldaprevir and pegylated interferon α-2a/ribavirin in individuals co-infected with hepatitis C virus genotype-1 and HIV. AIDS (2015) 0.75
Are HIV-infected donors suitable for renal transplantation? Transplantation (2011) 0.75
[Renal transplantation in patients with HIV infection]. Enferm Infecc Microbiol Clin (2005) 0.75
Toll-like receptor 4 polymorphisms and aspergillosis. N Engl J Med (2009) 0.75
Hyperlactatemia in patients with non-acetaminophen-related acute liver failure. World J Gastroenterol (2006) 0.75
Natalizumab-associated progressive multifocal leukoencephalopathy. N Engl J Med (2012) 0.75